Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 12, Issue 570, Pages eabb3791
Publisher
American Association for the Advancement of Science (AAAS)
Online
2020-11-19
DOI
10.1126/scitranslmed.abb3791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimicrobial Resistance in ESKAPE Pathogens
- (2020) David M. P. De Oliveira et al. CLINICAL MICROBIOLOGY REVIEWS
- Drug repurposing for antimicrobial discovery
- (2019) Maya A. Farha et al. Nature Microbiology
- Assembly of long, error-prone reads using repeat graphs
- (2019) Mikhail Kolmogorov et al. NATURE BIOTECHNOLOGY
- Neisseria gonorrhoeae Becomes Susceptible to Polymyxin B and Colistin in the Presence of PBT2
- (2019) Freda E.-C. Jen et al. ACS Infectious Diseases
- The Metal Theory of Alzheimer's Disease
- (2018) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
- (2018) Lisa Bohlmann et al. mBio
- Discovery of mcr-1-Mediated Colistin Resistance in a Highly Virulent Escherichia coli Lineage
- (2018) Brian M. Forde et al. mSphere
- Zinc in Cellular Regulation: The Nature and Significance of “Zinc Signals”
- (2017) Wolfgang Maret INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections
- (2017) Pamela Brown et al. JOURNAL OF ANTIBIOTICS
- Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae
- (2017) Lisa M Leung et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli
- (2017) Minh-Duy Phan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence and genetic characteristics of carbapenem-resistant Enterobacteriaceae strains in China
- (2017) Rong Zhang et al. LANCET INFECTIOUS DISEASES
- Recent advances and perspectives in the design and development of polymyxins
- (2017) Francesc Rabanal et al. NATURAL PRODUCT REPORTS
- Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
- (2016) C. Hauck et al. CLINICAL MICROBIOLOGY AND INFECTION
- High prevalence of ESBL-producingEscherichia coliandKlebsiella pneumoniaein community-onset bloodstream infections in China
- (2016) Jingjing Quan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Alternatives to antibiotics—a pipeline portfolio review
- (2016) Lloyd Czaplewski et al. LANCET INFECTIOUS DISEASES
- Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
- (2016) Gerard D. Wright TRENDS IN MICROBIOLOGY
- The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions
- (2016) Nicholas Jochumsen et al. Nature Communications
- When the drugs don't work
- (2016) Nature Microbiology
- A review of global initiatives to fight antibiotic resistance and recent antibiotics׳ discovery
- (2016) Arpana Sagwal Chaudhary Acta Pharmaceutica Sinica B
- Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
- (2015) Zubair A. Qureshi et al. CLINICAL INFECTIOUS DISEASES
- A review on colistin nephrotoxicity
- (2015) Atefeh Ordooei Javan et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Synthetic M Protein Peptide Synergizes with a CXC Chemokine Protease To Induce Vaccine-Mediated Protection against Virulent Streptococcal Pyoderma and Bacteremia
- (2015) Manisha Pandey et al. JOURNAL OF IMMUNOLOGY
- Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
- (2015) LANCET NEUROLOGY
- Erratum: Corrigendum: Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism
- (2015) Fiona Cuskin et al. NATURE
- Manganese Homeostasis in Group A Streptococcus Is Critical for Resistance to Oxidative Stress and Virulence
- (2015) Andrew G. Turner et al. mBio
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
- (2015) Hosam M. Zowawi et al. Scientific Reports
- Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
- (2014) Tony Velkov et al. ACS Chemical Biology
- Treating infections caused by carbapenemase-producing Enterobacteriaceae
- (2014) L.S. Tzouvelekis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement
- (2014) Bruce J. Walker et al. PLoS One
- Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae
- (2013) Tony Velkov et al. Innate Immunity
- Platforms for antibiotic discovery
- (2013) Kim Lewis NATURE REVIEWS DRUG DISCOVERY
- Acinetobacter baumannii: evolution of a global pathogen
- (2013) Luísa C.S. Antunes et al. Pathogens and Disease
- Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
- (2008) Lars Lannfelt et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search